Screening for ovarian cancer: recommendation statement.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Cancer of the ovary, fallopian tube, and peritoneum: 2025 update.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
   Review
2. Dysregulated expression of long noncoding RNAs in gynecologic cancers.Molecular cancer · 2017
   Review
3. Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms.Oncology letters · 2015
   Article
4. [A retrospective study of ovarian cancer with a median follow of 42 months].The Pan African medical journal · 2015
   Article
5. Prophylactic bilateral oophorectomy at time of hysterectomy for women at low risk: acog revises practice guidelines for ovarian cancer screening in low-risk women.Current oncology (Toronto, Ont.) · 2014
   Article
6. Ovarian cancer screening practices of obstetricians and gynecologists in puerto rico.BioMed research international · 2014
   Article
7. Biomarker testing for ovarian cancer: clinical utility of multiplex assays.Molecular diagnosis & therapy · 2013
   Review
8. Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists.American journal of obstetrics and gynecology · 2013
   Article
9. Current recommendations for cervical cancer screening: do they render the annual pelvic examination obsolete?Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2013
   Review
10. Surgical menopause and nonvertebral fracture risk among older US women.Menopause (New York, N.Y.) · 2012
    Article
11. Protein biomarkers of ovarian cancer: the forest and the trees.Future oncology (London, England) · 2012
    Review
12. Update in women's health for the general internist.Journal of general internal medicine · 2011
    Review
13. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.Social science & medicine (1982) · 2010
    Article
14. Developing Family Healthware, a family history screening tool to prevent common chronic diseases.Preventing chronic disease · 2009
    Article
15. Ovarian cancer screening.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2004
    Review
16. Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019-2020.Journal of mid-life health
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as